Keratinocyte G2/M Growth Arrest by 1,25-Dihydroxyvitamin D3 Is Caused by Cdc2 Phosphorylation Through Wee1 and Myt1 Regulation
- 1 June 2004
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 122 (6) , 1356-1364
- https://doi.org/10.1111/j.0022-202x.2004.22522.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- ΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpointOncogene, 2002
- Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 ActivityJournal of Biological Chemistry, 1997
- Myt1: a Wee1-type kinase that phosphorylates Cdc2 on residue Thr14Published by Springer Nature ,1997
- Cdc2 regulatory factorsCurrent Opinion in Cell Biology, 1994
- Efficacy of Vitamin D3 Derivatives in the Treatment of Psoriasis Vulgaris: A Preliminary ReportMayo Clinic Proceedings, 1993
- Crystal structure of cyclin-dependent kinase 2Nature, 1993
- Mechanisms of p34cdc2 regulation.Molecular and Cellular Biology, 1993
- Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris: A randomized, double-blind, right/left comparative, vehicle-controlled studyJournal of the American Academy of Dermatology, 1992
- The cdc25 protein contains an intrinsic phosphatase activityCell, 1991
- Effects of 1,25‐dihydroxyvitamin D3 on cell‐cycle kinetics of T 47D human breast cancer cellsJournal of Cellular Physiology, 1989